RIL
RNAM

Rothschild Investment LLC’s Avidity Biosciences RNAM Stock Holding History

Rothschild Investment LLC’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-187
Closed -$13.5K – 3664
2025
Q4 		$13.5K Sell
187
-3
-2% -$194 ﹤0.01% 1472
2025
Q3 		$8.28K Sell
190
-15
-7% -$606 ﹤0.01% 1516
2025
Q2 		$5.82K Sell
205
-15
-7% -$447 ﹤0.01% 1439
2025
Q1 		$6.49K Buy
220
+175
+389% +$5.45K ﹤0.01% 1319
2024
Q4 		$1.31K Sell
45
-60
-57% -$2.51K ﹤0.01% 2053
2024
Q3 		$4.82K Buy
105
+60
+133% +$2.6K ﹤0.01% 1307
2024
Q2 		$1.84K Buy
45
+40
+800% +$1.15K ﹤0.01% 1426
2024
Q1 		$128 Buy
+5
New +$78 ﹤0.01% 2047

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Rothschild Investment LLC's RNAM Position: Q1 2026 in Review

Rothschild Investment LLC sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 187 shares — an estimated $13.5K sold.

Rothschild Investment LLC first reported a position in RNAM in Q1 2024 and held it in 8 quarters. The position peaked at $13.5K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Rothschild Investment LLC reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 187 Avidity Biosciences shares in Q1 2026, an estimated $13.5K.
  • Rothschild Investment LLC first reported a position in Avidity Biosciences in Q1 2024 and held it in 8 quarters.
  • Rothschild Investment LLC's Avidity Biosciences position peaked at $13.5K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.